Literature DB >> 15244452

Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme.

Brian A Vernaglia1, Jia Huang, Eliana D Clark.   

Abstract

The formation of amyloid fibrils is an intractable problem in which normally soluble protein polymerizes and forms insoluble ordered aggregates. Such aggregates can range from being a nuisance in vitro to being toxic in vivo. The latter is true for lysozyme, which has been shown to form toxic deposits in humans. In the present study, the effects of partial denaturation of hen egg-white lysozyme via incubation in a concentrated solution of the denaturant guanidine hydrochloride are investigated. Results show that when lysozyme is incubated under moderate guanidine hydrochloride concentrations (i.e., 2-5 M), where lysozyme is partially unfolded, fibrils form rapidly. Thioflavin T, Congo red, X-ray diffraction, transmission electron microscopy, atomic force microscopy, and circular dichroism spectroscopy are all used to verify the production of fibrils under these conditions. Incubation at very low or very high guanidine hydrochloride concentrations fails to produce fibrils. At very low denaturant concentrations, the structure of lysozyme is fully native and very stable. On the other hand, at very high denaturant concentrations, guanidine hydrochloride is capable of dissolving and dis-aggregating fibrils that are formed. Raising the temperature and/or concentration of lysozyme accelerates fibril formation by further adding to the concentration of partially unfolded species. The addition of preformed fibrils also accelerates fibril formation but only under partially unfolding conditions. The results presented here provide further evidence that partial unfolding is a prerequisite to fibril formation. Partial denaturation can accelerate fibril formation in much the same way that mutations have been shown to accelerate fibril formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15244452     DOI: 10.1021/bm0498979

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  32 in total

1.  Kinetics of surfactant-induced aggregation of lysozyme studied by fluorescence spectroscopy.

Authors:  Neha Jain; Mily Bhattacharya; Samrat Mukhopadhyay
Journal:  J Fluoresc       Date:  2010-10-16       Impact factor: 2.217

2.  Amyloid fibril formation can proceed from different conformations of a partially unfolded protein.

Authors:  Martino Calamai; Fabrizio Chiti; Christopher M Dobson
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

3.  Protein particulates: another generic form of protein aggregation?

Authors:  Mark R H Krebs; Glyn L Devlin; A M Donald
Journal:  Biophys J       Date:  2006-11-17       Impact factor: 4.033

4.  Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin.

Authors:  Sheldon Park; Jeffery G Saven
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

5.  Hen lysozyme amyloid fibrils induce aggregation of erythrocytes and lipid vesicles.

Authors:  Nitin Chaudhary; Ramakrishnan Nagaraj
Journal:  Mol Cell Biochem       Date:  2009-03-26       Impact factor: 3.396

6.  Isolating toxic insulin amyloid reactive species that lack β-sheets and have wide pH stability.

Authors:  Caryn L Heldt; Dmitry Kurouski; Mirco Sorci; Elizabeth Grafeld; Igor K Lednev; Georges Belfort
Journal:  Biophys J       Date:  2011-06-08       Impact factor: 4.033

7.  Protein fibrillation lag times during kinetic inhibition.

Authors:  Rodrigo S Pagano; Máximo López Medus; Gabriela E Gómez; Paula M Couto; María S Labanda; Lucas Landolfo; Cecilia D'Alessio; Julio J Caramelo
Journal:  Biophys J       Date:  2014-08-05       Impact factor: 4.033

8.  The 8 and 5 kDa fragments of plasma gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68 kDa fragment is not amyloidogenic.

Authors:  James P Solomon; Isaac T Yonemoto; Amber N Murray; Joshua L Price; Evan T Powers; William E Balch; Jeffery W Kelly
Journal:  Biochemistry       Date:  2009-12-08       Impact factor: 3.162

9.  Acridine derivatives inhibit lysozyme aggregation.

Authors:  Zuzana Gazova; Andrea Bellova; Zuzana Daxnerova; Jan Imrich; Pavol Kristian; Jana Tomascikova; Jaroslava Bagelova; Diana Fedunova; Marian Antalik
Journal:  Eur Biophys J       Date:  2008-04-03       Impact factor: 1.733

Review 10.  Lessons learned from protein aggregation: toward technological and biomedical applications.

Authors:  César L Avila; Silvina Chaves; Sergio B Socias; Esteban Vera-Pingitore; Florencia González-Lizárraga; Cecilia Vera; Diego Ploper; Rosana Chehín
Journal:  Biophys Rev       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.